555 related articles for article (PubMed ID: 25500100)
1. Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial.
Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; DiPetrillo TA; Meyers BF; Heron DE; Hillman SL; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB;
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):718-25; discussion 725-6. PubMed ID: 25500100
[TBL] [Abstract][Full Text] [Related]
2. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron D; Jones DR; Daly BD; Starnes SL; Hatter JE; Putnam JB
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):554-62. PubMed ID: 21724195
[TBL] [Abstract][Full Text] [Related]
3. Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
Kent MS; Mandrekar SJ; Landreneau R; Nichols F; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
Ann Thorac Surg; 2016 Jul; 102(1):230-8. PubMed ID: 27101728
[TBL] [Abstract][Full Text] [Related]
4. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
Fernando HC; Landreneau RJ; Mandrekar SJ; Hillman SL; Nichols FC; Meyers B; DiPetrillo TA; Heron DE; Jones DR; Daly BD; Starnes SL; Tan A; Putnam JB
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1143-51. PubMed ID: 21872277
[TBL] [Abstract][Full Text] [Related]
5. Quality of life evolution after lung cancer surgery: a prospective study in 100 patients.
Balduyck B; Hendriks J; Lauwers P; Van Schil P
Lung Cancer; 2007 Jun; 56(3):423-31. PubMed ID: 17306905
[TBL] [Abstract][Full Text] [Related]
6. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
[TBL] [Abstract][Full Text] [Related]
7. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients.
Kent M; Landreneau R; Mandrekar S; Hillman S; Nichols F; Jones D; Starnes S; Tan A; Putnam J; Meyers B; Daly B; Fernando HC
Ann Thorac Surg; 2013 Nov; 96(5):1747-54; discussion 1754-5. PubMed ID: 23998400
[TBL] [Abstract][Full Text] [Related]
8. A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).
Kent MS; Mandrekar SJ; Landreneau R; Nichols F; Foster NR; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
Ann Thorac Surg; 2016 Jul; 102(1):239-46. PubMed ID: 27101729
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and survival after II stage nonsmall cell carcinoma surgery: Video-assisted thoracic surgery versus thoracotomy lobectomy.
Zhao J; Zhao Y; Qiu T; Jiao W; Xuan Y; Wang X; Wang Y; Luo Y
Indian J Cancer; 2015 Dec; 52 Suppl 2():e130-3. PubMed ID: 26728671
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
Crabtree T; Puri V; Timmerman R; Fernando H; Bradley J; Decker PA; Paulus R; Putnum JB; Dupuy DE; Meyers B
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):692-9. PubMed ID: 23174176
[TBL] [Abstract][Full Text] [Related]
12. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
[TBL] [Abstract][Full Text] [Related]
13. [Quality of life after lobectomy for early stage non-small cell lung cancer--video-assisted thoracoscopic surgery versus minimal incision thoracotomy].
Long H; Lin ZC; Lin YB; Situ DR; Wang YN; Rong TH
Ai Zheng; 2007 Jun; 26(6):624-8. PubMed ID: 17562269
[TBL] [Abstract][Full Text] [Related]
14. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
[TBL] [Abstract][Full Text] [Related]
15. The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer.
Schulte T; Schniewind B; Dohrmann P; Küchler T; Kurdow R
Chest; 2009 Feb; 135(2):322-329. PubMed ID: 18689576
[TBL] [Abstract][Full Text] [Related]
16. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
[TBL] [Abstract][Full Text] [Related]
18. Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer.
Pompili C; Salati M; Refai M; Berardi R; Onofri A; Mazzanti P; Brunelli A
Eur J Cardiothorac Surg; 2013 May; 43(5):905-10. PubMed ID: 23091229
[TBL] [Abstract][Full Text] [Related]
19. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
Trials; 2016 Apr; 17():191. PubMed ID: 27053091
[TBL] [Abstract][Full Text] [Related]
20. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?
Chambers A; Routledge T; Pilling J; Scarci M
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1015-21. PubMed ID: 20354037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
